FDA.reportPublic FDA data

revefenacin 175 MCG in 3 ML Inhalation Solution

RxCUI
2102779
RxNorm name
revefenacin 175 MCG in 3 ML Inhalation Solution
Display name
revefenacin 175 MCG in 3 ML Inhalation Solution
Full name
revefenacin 175 MCG in 3 ML Inhalation Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
YUPELRIREVEFENACINViatris Specialty LLC6dfebf04-7c90-436a-9b16-750d3c1ee0a62022-05-03Warnings, Adverse reactionsExact identifier
rxcui: 2102779

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6dfebf04-7c90-436a-9b16-750d3c1ee0a6revefenacin 175 MCG in 3 ML Inhalation Solution [PSN] · revefenacin 0.0583 MG/ML Inhalation Solution [SCD] · revefenacin 175 MCG per 3 ML Inhalation Solution [SY]315These highlights do not include all the information needed to use YUPELRI ® safely and effectively. See full prescribing information for YUPELRI. YUPELRI (revefenacin) inhalation solution, for oral inhalation Initial U.S. Approval: 201820220503